Antipodes Partners LTD Alcon Inc Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Alcon Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 652,329 shares of ALC stock, worth $51.3 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
652,329
Previous 1,129,090
42.23%
Holding current value
$51.3 Million
Previous $99.7 Million
51.24%
% of portfolio
1.2%
Previous 3.32%
Shares
5 transactions
Others Institutions Holding ALC
# of Institutions
759Shares Held
257MCall Options Held
14.4MPut Options Held
3.86M-
Vanguard Group Inc Valley Forge, PA21.2MShares$1.67 Billion0.02% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.22 Billion1.27% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL11.7MShares$916 Million0.22% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA11.1MShares$871 Million2.0% of portfolio
-
Zurcher Kantonalbank (Zurich Cantonalbank) Zurich, V89.14MShares$719 Million2.07% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $38.5B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...